Hormonal
Pharmacological activation of brown adipose tissue (BAT) and induction of 'browning' in white adipose tissue (WAT) via agents such as β3-adrenergic receptor agonists, thyroid receptor agonists, and GLP-1-based multi-agonists enhances energy expenditure and improves metabolic parameters, offering a potential therapeutic avenue for obesity management.
This research suggests that certain medications (like GLP-1 agonists or specific receptor agonists) may help manage obesity not just by suppressing appetite, but by actively turning on your body's internal heating system (brown fat). This process burns energy as heat, which can improve blood sugar and lipid levels. While this might not always lead to massive weight loss on its own, it addresses the metabolic slowdown that often hinders long-term weight management.
Based on recent findings, brown adipose tissue-activating agents could represent another option in addition to appetite inhibitors and inhibitors of nutrient absorption for obesity treatment.
Why this rating
The paper is a review summarizing various preclinical and clinical studies; evidence quality varies by specific drug and study size.
Source
Pharmacological modulation of adaptive thermogenesis: new clues for obesity management?
Valentina Annamaria Genchi et al. · Journal of Endocrinological Investigation · 2023
DOI 10.1007/s40618-023-02125-0
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →